Gene interactions in gonadal development

被引:81
作者
Parker, KL [1 ]
Schedl, A
Schimmer, BP
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA
[3] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
[4] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada
关键词
sex determination; SF-1; WT1; DAX-1;
D O I
10.1146/annurev.physiol.61.1.417
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The acquisition of a sexually dimorphic phenotype is a critical event in mammalian development. Although the maturation of sexual function and reproduction occurs after birth, essentially all of the critical developmental steps take place during embryogenesis. Temporally, these steps can be divided into two different phases: sex determination, the initial event that determines whether the gonads will develop as testes or ovaries; and sexual differentiation, the subsequent events that ultimately produce either the male or the female sexual phenotype. A basic tenet of sexual development in mammals is that genetic sex-determined by the presence or absence of the Y chromosome-directs the embryonic gonads to differentiate into either testes or ovaries. Thereafter, hormones produced by the testes direct the developmental program leading to male sexual differentiation. In the absence of testicular hormones, the pathway of sexual differentiation is female. This chapter reviews the anatomic and cellular changes that constitute sexual differentiation and discusses SRY and other genes, including SF-I, WT1, DAX-1, and SOX9, that play key developmental roles in this process. Dose-dependent interactions among these genes are critical for sex determination and differentiation.
引用
收藏
页码:417 / 433
页数:17
相关论文
共 95 条
[1]   THE EXPRESSION OF THE WILMS-TUMOR GENE, WT1, IN THE DEVELOPING MAMMALIAN EMBRYO [J].
ARMSTRONG, JF ;
PRITCHARDJONES, K ;
BICKMORE, WA ;
HASTIE, ND ;
BARD, JBL .
MECHANISMS OF DEVELOPMENT, 1993, 40 (1-2) :85-97
[2]   Donor splice-site mutations in WT1 are responsible for Frasier syndrome [J].
Barbaux, S ;
Niaudet, P ;
Gubler, MC ;
Grunfeld, JP ;
Jaubert, F ;
Kuttenn, F ;
Fekete, CN ;
SouleyreauTherville, N ;
Thibaud, E ;
Fellous, M ;
McElreavey, K .
NATURE GENETICS, 1997, 17 (04) :467-470
[3]   A DOSAGE SENSITIVE LOCUS AT CHROMOSOME XP21 IS INVOLVED IN MALE TO FEMALE SEX REVERSAL [J].
BARDONI, B ;
ZANARIA, E ;
GUIOLI, S ;
FLORIDIA, G ;
WORLEY, KC ;
TONINI, G ;
FERRANTE, E ;
CHIUMELLO, G ;
MCCABE, ERB ;
FRACCARO, M ;
ZUFFARDI, O ;
CAMERINO, G .
NATURE GENETICS, 1994, 7 (04) :497-501
[4]   GENETIC-EVIDENCE EQUATING SRY AND THE TESTIS-DETERMINING FACTOR [J].
BERTA, P ;
HAWKINS, JR ;
SINCLAIR, AH ;
TAYLOR, A ;
GRIFFITHS, BL ;
GOODFELLOW, PN ;
FELLOUS, M .
NATURE, 1990, 348 (6300) :448-450
[5]   MODULATION OF DNA-BINDING SPECIFICITY BY ALTERNATIVE SPLICING OF THE WILMS-TUMOR WT1 GENE TRANSCRIPT [J].
BICKMORE, WA ;
OGHENE, K ;
LITTLE, MH ;
SEAWRIGHT, A ;
VANHEYNINGEN, V ;
HASTIE, ND .
SCIENCE, 1992, 257 (5067) :235-237
[6]   A non-AUG translational initiation event generates novel WT1 isoforms [J].
Bruening, W ;
Pelletier, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8646-8654
[7]   GERMLINE INTRONIC AND EXONIC MUTATIONS IN THE WILMS-TUMOR GENE (WT1) AFFECTING UROGENITAL DEVELOPMENT [J].
BRUENING, W ;
BARDEESY, N ;
SILVERMAN, BL ;
COHN, RA ;
MACHIN, GA ;
ARONSON, AJ ;
HOUSMAN, D ;
PELLETIER, J .
NATURE GENETICS, 1992, 1 (02) :144-148
[8]   IDENTIFICATION OF A PUTATIVE STEROIDOGENIC FACTOR-I RESPONSE ELEMENT IN THE DAX-1 PROMOTER [J].
BURRIS, TP ;
GUO, WW ;
LE, T ;
MCCABE, ERB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (02) :576-581
[9]   ISOLATION AND CHARACTERIZATION OF A ZINC FINGER POLYPEPTIDE GENE AT THE HUMAN CHROMOSOME-11 WILMS TUMOR LOCUS [J].
CALL, KM ;
GLASER, T ;
ITO, CY ;
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
ROSE, EA ;
KRAL, A ;
YEGER, H ;
LEWIS, WH ;
JONES, C ;
HOUSMAN, DE .
CELL, 1990, 60 (03) :509-520
[10]  
Cameron FJ, 1997, HUM MUTAT, V9, P388